Education
About Us
Working with TipRanks
Follow Us
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
:REKA
REKA Stock Chart & Stats
Day’s Range― - ―
52-Week Range1,130.00 - 1,601.00
Previous CloseN/A
Volume1.49K
Average Volume (3M)1.06K
Market Cap
139.72M
Enterprise Value263.42M
Total Cash (Recent Filing)7.80M
Total Debt (Recent Filing)128.27M
Price to Earnings (P/E)53.8
Beta0.38
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Apr 06, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding11,523,922
10 Day Avg. Volume1,421
30 Day Avg. Volume1,061
Financial Highlights & Ratios
PEG Ratio3.19
Price to Book (P/B)0.90
Price to Sales (P/S)0.00
P/FCF Ratio6.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
REKA FAQ
What was Rekah Pharmaceutical Industry Ltd.’s price range in the past 12 months?
Rekah Pharmaceutical Industry Ltd. lowest stock price was 1130.00 and its highest was 1601.00 in the past 12 months.
What is Rekah Pharmaceutical Industry Ltd.’s market cap?
Rekah Pharmaceutical Industry Ltd.’s market cap is 139.72M.
When is Rekah Pharmaceutical Industry Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rekah Pharmaceutical Industry Ltd.’s earnings last quarter?
Currently, no data Available
Is Rekah Pharmaceutical Industry Ltd. overvalued?
According to Wall Street analysts Rekah Pharmaceutical Industry Ltd.’s price is currently Overvalued.
Does Rekah Pharmaceutical Industry Ltd. pay dividends?
Rekah Pharmaceutical Industry Ltd. pays a Annually dividend of 86.776 which represents an annual dividend yield of N/A. See more information on Rekah Pharmaceutical Industry Ltd. dividends here
What is Rekah Pharmaceutical Industry Ltd.’s EPS estimate?
Rekah Pharmaceutical Industry Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rekah Pharmaceutical Industry Ltd. have?
Rekah Pharmaceutical Industry Ltd. has 11,523,922 shares outstanding.
What happened to Rekah Pharmaceutical Industry Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rekah Pharmaceutical Industry Ltd.?
Currently, no hedge funds are holding shares in IL:REKA
Company Description
Rekah Pharmaceutical Industry Ltd.
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.